CONTENT

ISCIII/ PI14/01058: Preclinical evaluation of immunoregulatory molecules in combination with latency reactivators for the development of new HIV-1 erradication strategies

Actiu

Date: 01/01/2015

Duration: : 3 years

Financing entity: Instituto de Salud Carlos III (ISCIII)

Research Supervisor(s): Julia G.Prado

Participant entities: Institute for AIDS Research IrsiCaixa

IrsiCaixa linked groups: Virus Immune Escape and Vaccine design (VIRIEVAC)